Surgical, medical and radiation oncology experts at Johns Hopkins work together as a team to coordinate care for bladder cancer patients.
They continue ground-breaking research and clinical trials to improve detection and treatment.
Surgical Innovation in Management of Invasive Bladder Cancer Treatments
"Nerve sparing" cystoprostatectomy
Surgical treatment of patients with genitourinary malignancies remains a paramount interest of the faculty and staff of the Brady Urological Institute; and that interest extends importantly to patients with all forms of bladder cancer.
If you would like to schedule an appointment with us, please call 410-955-6707 for Johns Hopkins Hospital Outpatient Center or 202-660-5561 for Sibley Memorial Hospital
Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.
J Urol. 1987 Dec;138(6):1402-6.
The disease-specific survival of men undergoing this types of surgery as well as data on potency after the operation appear below:
Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
J Urol. 1996 Feb; 155(2):490-4.
The surgical intervention for invasive bladder cancer is routine and well organized at Johns Hopkins. Complete preoperative consultation, imaging, endoscopic evaluation and expert review of biopsy material and laboratory and x-ray data are accomplished by the faculty and staff of the Institute. All forms of urinary tract reconstruction including ileal-conduit, continent catheterizable and orthoptic neobladder reconstruction are routinely performed at Johns Hopkins.